CIK 0001425205
- Accelerated filer
IOVANCE BIOTHERAPEUTICS, INC.
Sign in to watch- Ticker
- IOVA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 753254381
- Phone
- +1 650-260-7120
- Business address
- 825 INDUSTRIAL ROAD, 4TH FLOOR, SAN CARLOS, CA, 94070
- Former names
- Lion Biotechnologies, Inc., Genesis Biopharma, Inc, FREIGHT MANAGEMENT CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 99 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-16 | Countouriotis Athena Director | Grant or award · Deferred Restricted Stock Unit | +90,316 | 90,316 | ||
| 2025-06-13 | Countouriotis Athena Director | Grant or award · Deferred Restricted Stock Unit | +67,546 | 67,546 | ||
| 2024-06-11 | Countouriotis Athena Director | Grant or award · Deferred Restricted Stock Unit | +49,303 | 49,303 | ||
| 2024-03-01 | Countouriotis Athena Director | Grant or award · Deferred Restricted Stock Unit | +50,000 | 50,000 | ||
| 2023-06-06 | Countouriotis Athena Director | Grant or award · Deferred Restricted Stock Unit | +51,955 | 51,955 | ||
| 2022-06-10 | Countouriotis Athena Director | Grant or award · Deferred Restricted Stock Unit | +51,204 | 51,204 | ||
| 2021-06-29 | Countouriotis Athena Director | Grant or award · Stock Option (right to buy) | +35,000 | 35,000 | ||
| 2020-06-08 | Countouriotis Athena Director | Grant or award · Stock Option (right to buy) | +35,000 | 35,000 |
Page 1 of 1 · 8 trades